Projected Income Statement: Genpact Limited

Forecast Balance Sheet: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 756 780 683 573 688 450 -434 -1,115
Change - 3.17% -12.44% -16.11% 20.07% -34.64% -196.44% -156.91%
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 53.34 50.61 55.42 82.77 78.2 87.1 87.11 120.2
Change - -5.11% 9.5% 49.34% -5.51% 11.37% 0.02% 38.01%
Free Cash Flow (FCF) 1 640.9 393.1 435.4 532.7 734.7 637 704.7 783
Change - -38.68% 10.77% 22.34% 37.92% -13.29% 10.62% 11.12%
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Genpact Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.19% 18.42% 18.66% 18.54% 18.86% 18.75% 19.25% 19.46%
EBIT Margin (%) 16.48% 16.43% 17.04% 17.07% 17.47% 17.65% 17.91% 18.02%
EBT Margin (%) 12.01% 10.64% 13.45% 14.2% 14.37% 14.66% 14.98% 15.05%
Net margin (%) 9.19% 8.08% 14.1% 10.78% 10.88% 11.13% 11.38% 11.5%
FCF margin (%) 15.94% 8.99% 9.73% 11.17% 14.46% 11.72% 12.1% 12.43%
FCF / Net Income (%) 173.49% 111.22% 68.97% 103.7% 132.97% 105.24% 106.33% 108.12%

Profitability

        
ROA 7.5% 7.1% 13.44% 10.49% 11.91% 11.25% 11.66% 11.32%
ROE 19.8% 18.63% 30.99% 22.15% 26.11% 25.13% 23.58% 21.16%

Financial Health

        
Leverage (Debt/EBITDA) 0.98x 0.97x 0.82x 0.65x 0.72x 0.44x - -
Debt / Free cash flow 1.18x 1.98x 1.57x 1.08x 0.94x 0.71x - -

Capital Intensity

        
CAPEX / Current Assets (%) 1.33% 1.16% 1.24% 1.74% 1.54% 1.6% 1.5% 1.91%
CAPEX / EBITDA (%) 6.91% 6.29% 6.63% 9.37% 8.16% 8.55% 7.77% 9.81%
CAPEX / FCF (%) 8.32% 12.88% 12.73% 15.54% 10.64% 13.67% 12.36% 15.35%

Items per share

        
Cash flow per share 1 3.598 2.366 2.677 3.411 4.602 3.818 4.618 5.67
Change - -34.24% 13.14% 27.41% 34.92% -17.04% 20.97% 22.76%
Dividend per Share 1 0.43 0.5 0.55 0.61 - 0.7443 0.8328 0.9075
Change - 16.28% 10% 10.91% - - 11.89% 8.97%
Book Value Per Share 1 10.04 10.37 9.864 13.68 14.43 16.3 20.59 25.48
Change - 3.35% -4.89% 38.71% 5.49% 12.98% 26.28% 23.74%
EPS 1 1.91 1.88 3.41 2.85 3.13 3.548 3.935 4.383
Change - -1.57% 81.38% -16.42% 9.82% 13.35% 10.91% 11.38%
Nbr of stocks (in thousands) 188,060 183,258 181,412 176,361 172,414 168,034 168,034 168,034
Announcement Date 2/11/22 2/9/23 2/8/24 2/6/25 2/5/26 - - -
1USD
Estimates
2026 *2027 *
P/E 10.7x 9.66x
PBR 2.33x 1.85x
EV / Sales 1.26x 1.02x
Yield 1.96% 2.19%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
38.02USD
Average target price
42.18USD
Spread / Average Target
+10.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. G Stock
  4. Financials Genpact Limited